REQUEST A DEMO
Total
USD $0.00
Search more companies

Hemocard S A S (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Hemocard S A S Profile Updated: March 13, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Hemocard S A S is a company in Colombia, with a head office in Bogota D.C.. It operates in the Ambulatory Health Care Services industry. The company was established on April 21, 2016. Hemocard S A S currently employs 2 (2025) people. From the latest financial highlights, Hemocard S A S reported a net sales revenue increase of 48.57% in 2024. Its’ total assets recorded a growth of 31.87%. The net profit margin of Hemocard S A S increased by 4.02% in 2024.

Headquarters
Cra 13 # 49-40 Consultorio 430
Bogota D.C.; Bogota D.C; Postal Code: 0202

Contact Details: Purchase the Hemocard S A S report to view the information.

Basic Information
Total Employees:
Purchase the Hemocard S A S report to view the information.
Financial Auditors:
Purchase the Hemocard S A S report to view the information.
Incorporation Date:
April 21, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Hemocard S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
48.57%
Total operating revenue
48.57%
Operating profit (EBIT)
64.01%
Net Profit (Loss) for the Period
85.29%
Total Assets
31.87%
Total Equity
22.96%
Operating Profit Margin (ROS)
3.01%
Net Profit Margin
4.02%
Return on Equity (ROE)
6.53%
Quick Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?